Cancer research

Israeli Prof. Dan Aderka’s findings could double the life expectancy for colorectal cancer patients.

By United with Israel Staff

A team led by Sheba Medical Center’s Prof. Dan Aderka recently made a major breakthrough in colorectal cancer research, discovering the power of different combined therapies for the pervasive and deadly disease.

Remarkably, Aderka answered a decade-old open question about which combinations of biological medicine and chemotherapy are most effective, in addition to providing insight into which order various therapies should be administered, reported the Jerusalem Post.

While one combination (Avastin and chemotherapy) added an average of 21 months to patients’ life expectancy, a different combination (Avastin and chemotherapy) added 40 months.

Colorectal cancer remains the third most common type of cancer, causing hundreds of thousands of deaths per year, affecting men at far higher rates than women.


Subscribe to Our FREE Newsletter for More Great Stories Like This One

United with Israel publishes stories like this every day. We believe that our work allows a more balanced view of Israel to emerge. With so much anti-Israel media bias out there from outlets like CNN and the BBC, helping the Holy Land means getting our message out to as many people as possible.

You can help.

Subscribe to our free newsletter to ensure that you get the latest and best stories from United with Israel. Together we can make a difference, and it starts with communication.


Source: United with Israel